Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,221 to 1,240 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promising targets for therapy of osteoarthritis: a review on the Wnt and TGF-β signalling pathways. | Ther Adv Musculoskelet Dis | 2021 | 33948125 | PubTator, text mining | PubMed |
| Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review. | Int J Mol Sci | 2021 | 33946583 | PubTator, text mining | PubMed |
| SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population. | J Clin Med | 2021 | 33925423 | PubTator, text mining | PubMed |
| A Roadmap of In Vitro Models in Osteoarthritis: A Focus on Their Biological Relevance in Regenerative Medicine. | J Clin Med | 2021 | 33925222 | PubTator, text mining | PubMed |
| Functional Expression, Purification and Identification of Interaction Partners of PACRG. | Molecules | 2021 | 33923444 | PubTator, text mining | PubMed |
| Minimal Disease Monitoring in Pediatric Non-Hodgkin's Lymphoma: Current Clinical Application and Future Challenges. | Cancers (Basel) | 2021 | 33921029 | PubTator, text mining | PubMed |
| Founder Effects in Hereditary Hemorrhagic Telangiectasia. | J Clin Med | 2021 | 33919892 | PubTator, text mining | PubMed |
| Diagnostic Yield of Genetic Testing in Sudden Cardiac Death with Autopsy Findings of Uncertain Significance. | J Clin Med | 2021 | 33919104 | PubTator, text mining | PubMed |
| The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking. | Cancers (Basel) | 2021 | 33917287 | PubTator, text mining | PubMed |
| Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour. | Ecancermedicalscience | 2021 | 33912240 | PubTator, text mining | PubMed |
| New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine. | Expert Opin Investig Drugs | 2021 | 33909517 | PubTator, text mining | PubMed |
| Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence. | BMC Cancer | 2021 | 33906629 | PubTator, text mining | PubMed |
| Splicing factor SRSF6 mediates pleural fibrosis. | JCI Insight | 2021 | 33905374 | PubTator, text mining | PubMed |
| A Case of an Inflammatory Myofibroblastic Tumor Mimicking Appendicitis. | Cureus | 2021 | 33898142 | PubTator, text mining | PubMed |
| Endoglin deficiency impairs VEGFR2 but not FGFR1 or TIE2 activation and alters VEGF-mediated cellular responses in human primary endothelial cells. | Transl Res | 2021 | 33894400 | PubTator, text mining | PubMed |
| Sarcomatoid Urothelial Carcinoma With Myxoid Stroma: A Case Report and Diagnostic Approach. | Cureus | 2021 | 33884248 | PubTator, text mining | PubMed |
| Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro. | J Transl Med | 2021 | 33874948 | PubTator, text mining | PubMed |
| A Non-canonical Wnt Signature Correlates With Lower Survival in Gastric Cancer. | Front Cell Dev Biol | 2021 | 33869179 | PubTator, text mining | PubMed |
| Janus-faced EPHB4-associated disorders: novel pathogenic variants and unreported intrafamilial overlapping phenotypes. | Genet Med | 2021 | 33864021 | PubTator, text mining | PubMed |
| Studying Tumor Angiogenesis and Cancer Invasion in a Three-Dimensional Vascularized Breast Cancer Micro-Environment. | Adv Biol (Weinh) | 2021 | 33857356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=62